Superworth

COMPASS Pathways EPS CMPS

Diluted earnings per share by quarter and over the last twelve months, from 2021.

Last 12 months, to Sep 30, 2026
−$3.47
Latest quarter, Q3 FY26
−$0.31
Fiscal year 2025
−$3.07

COMPASS Pathways' earnings per share was −$3.47 over the twelve months to Sep 30, 2026.

In its latest quarter, Q3 FY26, it was −$0.31.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$3.07n/a
FY2024−$2.30n/a
FY2023−$2.39n/a
FY2022−$2.16n/a
FY2021−$1.78n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q3 FY26−$0.31n/a−$3.47
Q2 FY26−$1.88n/a−$4.60
Q1 FY26−$0.30n/a−$3.13
Q4 FY25−$0.98n/a−$3.07
Q3 FY25−$1.44n/a−$2.72
Q2 FY25−$0.41n/a−$1.84
Q1 FY25−$0.24n/a−$1.99
Q4 FY24−$0.63n/a−$2.30
Q3 FY24−$0.56n/a−$2.20
Q2 FY24−$0.56n/a−$2.31
Q1 FY24−$0.55n/a−$2.37
Q4 FY23−$0.53n/a−$2.39

Against its peers

Companies in Drug Manufacturers - General nearest COMPASS Pathways' size, closest first, today.

CompanyEPS, 12 monthsGrowth
CMPSCOMPASS Pathways−$4.60
AMPHAmphastar Pharmaceuticals$1.70−36% a year
OMEROmeros$1.52
ANABAnaptysbio$4.57
PCRXPacira BioSciences$0.35
PAHCPhibro Animal Health$2.44+107% a year
ANIPANI Pharmaceuticals$4.70
ABUSArbutus Biopharma$0.78
COLLCollegium Pharmaceutical$1.24+19% a year
HRMYHarmony Biosciences$3.09−0% a year
ZVRAZevra Therapeutics$0.93
Peer median$1.61

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on COMPASS Pathways

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.